BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC)
CUSIP: 07725L102
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 1,448,978,913
- Total 13F shares
- 55,478,557
- Share change
- -421,496
- Total reported value
- $19,043,602,189
- Put/Call ratio
- 174%
- Price per share
- $343.19
- Number of holders
- 259
- Value change
- -$143,508,273
- Number of buys
- 137
- Number of sells
- 89
Quarterly Holders Quick Answers
What is CUSIP 07725L102?
CUSIP 07725L102 identifies ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07725L102:
Top shareholders of ONC - BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.81%
|
11,668,897
|
$4,061,710,000 | — | 31 Mar 2021 | |
| Capital International Investors |
13F
|
Company |
0.4%
|
5,797,151
|
$2,013,664,000 | — | 31 Mar 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.38%
|
5,472,259
|
$1,904,784,000 | — | 31 Mar 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.31%
|
4,428,715
|
$1,541,548,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
0.3%
|
4,416,495
|
$1,537,294,000 | — | 31 Mar 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.27%
|
3,888,839
|
$1,353,627,000 | — | 31 Mar 2021 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.19%
|
2,746,755
|
$956,090,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
2,609,596
|
$908,347,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.17%
|
2,488,500
|
$866,197,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.08%
|
1,194,984
|
$415,951,000 | — | 31 Mar 2021 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.07%
|
1,035,930
|
$360,587,000 | — | 31 Mar 2021 | |
| Howard Liang |
3/4/5
|
CFO & Chief Strategy Officer |
—
class O/S missing
|
1,553,149
|
$322,615,606 | — | 28 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.06%
|
850,000
|
$295,868,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
826,489
|
$287,684,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.05%
|
764,188
|
$265,999,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
729,930
|
$254,074,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
406,497
|
$141,493,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
256,015
|
$89,114,000 | — | 31 Mar 2021 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
243,492
|
$84,755,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
223,742
|
$77,880,000 | — | 31 Mar 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0.02%
|
222,859
|
$77,573,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
205,769
|
$71,624,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.01%
|
200,000
|
$69,616,000 | — | 31 Mar 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.01%
|
191,014
|
$66,488,153 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
184,646
|
$63,819,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
170,971
|
$59,511,000 | — | 31 Mar 2021 | |
| USS Investment Management Ltd |
13F
|
Company |
0.01%
|
168,000
|
$58,397,000 | — | 31 Mar 2021 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.01%
|
167,696
|
$58,372,000 | — | 31 Mar 2021 | |
| Capital Bank & Trust Co |
13F
|
Company |
0.01%
|
164,062
|
$57,107,000 | — | 31 Mar 2021 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.01%
|
159,974
|
$55,684,000 | — | 31 Mar 2021 | |
| Fiera Capital Corp |
13F
|
Company |
0.01%
|
151,301
|
$52,665,000 | — | 31 Mar 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
0.01%
|
150,000
|
$52,212,000 | — | 31 Mar 2021 | |
| NOMURA ASSET MANAGEMENT CO LTD |
13F
|
Company |
0.01%
|
147,963
|
$51,502,957 | — | 31 Mar 2021 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.01%
|
141,119
|
$49,121,000 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.01%
|
191,344
|
$47,492,000 | — | 31 Mar 2021 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.01%
|
119,782
|
$41,694,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.01%
|
118,856
|
$41,371,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
115,161
|
$40,085,000 | — | 31 Mar 2021 | |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP |
13F
|
Company |
0.01%
|
107,057
|
$37,264,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.01%
|
100,117
|
$34,849,000 | — | 31 Mar 2021 | |
| Capital International Sarl |
13F
|
Company |
0.01%
|
99,263
|
$34,551,000 | — | 31 Mar 2021 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.01%
|
97,572
|
$33,962,000 | — | 31 Mar 2021 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
83,008
|
$28,894,000 | — | 31 Mar 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.01%
|
82,401
|
$28,668,000 | — | 31 Mar 2021 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
81,407
|
$28,336,000 | — | 31 Mar 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
80,819
|
$28,131,000 | — | 31 Mar 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
80,481
|
$28,013,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
79,836
|
$27,791,000 | — | 31 Mar 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
76,312
|
$26,562,681 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
75,308
|
$26,214,000 | — | 31 Mar 2021 |
Institutional Holders of BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) as of Q2 2021
As of 30 Jun 2021,
BeOne Medicines Ltd. - Ordinary Shares, par value $0.0001 per share (ONC) was held by
259 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,478,557 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital International Investors, HHLR ADVISORS, LTD., FMR LLC, BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings (Private) Ltd, BlackRock Inc., Invesco Ltd., and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
261
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
241
Q2 2021 holders
259
Holder diff
18
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.